T细胞大颗粒淋巴细胞白血病免疫谱系特征的单细胞分析
该研究收集5例T-LGLL患者治疗前后及3名健康志愿者外周血,用10×Genomics单细胞转录组测序分析67 237个免疫细胞。发现效应CD8+ T细胞增多且毒性增殖增强、Treg减少且凋亡增加、APC功能增强、NK细胞毒性减弱但调节T细胞能力增强,免疫抑制治疗有效后CD8+ T细胞增殖与效应功能下降、Treg比例升高且凋亡通路下调(P<0.05)。
要点
- T-LGLL患者效应CD8+ T细胞数量增多、细胞毒性及增殖能力增强,有效免疫抑制治疗后增殖与效应功能下降(P<0.05)。
- T-LGLL患者Treg细胞比例减少且凋亡增加,治疗缓解后Treg比例升高、凋亡通路下调(P<0.05)。
- T-LGLL患者APC功能增强、NK细胞毒性减弱但调节T细胞能力增强(P<0.05)。
核心结论
- T-LGLL患者存在特征性免疫谱系,表现为免疫稳态失衡,突出特征为效应CD8+ T细胞异常活化伴数量增加、Treg细胞数量减少且功能失调。
- APC及NK细胞正向调控T淋巴细胞激活、分化和增殖。
研究设计与样本
- 收集2019年6月至2020年12月中国医学科学院血液病医院5例T-LGLL患者治疗前后及3名健康志愿者外周血。
- 应用10×Genomics技术进行单细胞转录组建库测序,比较患者与健康志愿者的免疫细胞差异基因并进行通路富集。
主要发现
- 共分析67 237个免疫细胞;T-LGLL患者效应CD8+ T细胞数量增多、细胞毒性及增殖能力增强。
- 免疫抑制治疗有效后效应CD8+ T细胞增殖能力及效应功能均下降(P<0.05)。
- T-LGLL患者Treg细胞比例减少且凋亡增加;免疫抑制治疗有效后Treg细胞比例升高、凋亡通路下调(P<0.05)。
- T-LGLL患者APC功能增强,单核细胞、树突状细胞富集到抗原合成与呈递通路,B细胞抗原结合能力增强并富集到T细胞活化相关通路(P<0.05)。
- T-LGLL患者NK细胞毒性杀伤功能减弱但对T细胞的调节能力增强(P<0.05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate alterations in the immune lineage of T-cell large granular lymphocytic leukemia (T-LGLL) at the single-cell transcriptome level and to elucidate its pathogenic mechanisms. Methods: Peripheral blood samples were collected from 5 T-LGLL patients before and after treatment (from June 2019 to December 2020) and 3 healthy controls at the Institute of Hematology & Blood Diseases Hospital, CAMS & PUMC. Single-cell transcriptome sequencing libraries were prepared and sequenced using 10× Genomics technology. Differentially expressed genes in immune cells were compared between patients and healthy donors, followed by pathway enrichment analyses. Results: Profiling 67,237 immune cells revealed that, in T-LGLL: 1) Effector CD8+ T cells exhibited increased numbers, enhanced cytotoxicity, and greater proliferative capacity. Following effective immunosuppressive therapy, both the proliferative capacity and effector functions of these cells significantly decreased (P<0.05). 2) The proportion of regulatory T (Treg) cells was reduced, accompanied by increased apoptosis. After effective immunosuppressive therapy leading to remission, Treg cell proportions increased, and apoptotic pathways were downregulated (P<0.05). 3) Antigen-presenting cells (APCs) showed enhanced functionality. Monocytes and dendritic cells were enriched in antigen synthesis and presentation pathways, while B cells displayed increased antigen-binding capacity and were enriched in pathways related to T-cell activation (P<0.05). 4) Natural killer (NK) cells exhibited attenuated cytotoxic function but demonstrated an enhanced regulatory capacity over T cells (P<0.05) . Conclusions: T-LGLL patients present a characteristic immunological profile marked by an imbalance in immune homeostasis. This profile includes abnormal activation and expansion of effector CD8(+) T cells, and a reduction in Treg cell numbers accompanied by functional impairment. Furthermore, APCs and NK cells were found to positively regulate T-lymphocyte activation, differentiation, and proliferation. 目的: 单细胞转录组层面解析T细胞大颗粒淋巴细胞白血病(T-LGLL)免疫谱系变化,探索其致病机制。 方法: 收集2019年6月至2020年12月中国医学科学院血液病医院收治的5例T-LGLL患者治疗前后及3名健康志愿者外周血,应用10×Genomics技术进行单细胞转录组建库测序,比较患者与健康志愿者的免疫细胞差异基因并进行通路富集。 结果: 通过对67 237个免疫细胞分析,发现T-LGLL患者疾病状态下:①效应CD8(+) T细胞数量增多、细胞毒性及增殖能力增强,免疫抑制治疗有效后效应CD8(+) T细胞增殖能力及效应功能均下降(P<0.05);②调节性T(Treg)细胞比例减少且凋亡增加,免疫抑制治疗有效后Treg细胞比例升高,凋亡通路下调(P<0.05);③抗原提呈细胞(APC)功能增强,单核细胞、树突状细胞均可富集到抗原合成与呈递通路,B细胞抗原结合能力增强,富集到与T细胞活化相关通路(P<0.05);④自然杀伤(NK)细胞的毒性杀伤功能减弱,但对T细胞的调节能力增强(P<0.05)。 结论: T-LGLL患者存在特征性免疫谱系,表现为免疫稳态的失衡,突出的特征为效应CD8(+) T细胞异常活化伴数量增加,Treg细胞数量减少且功能失调;APC及NK细胞正向调控T淋巴细胞激活、分化和增殖。.
引用
- Huang K, Zhang LL, Qiu C, et al. [Single-cell analysis of immune-lineage features in T-cell large granular lymphocytic leukemia]. Zhonghua Xue Ye Xue Za Zhi. 2025. PMID: 40623905. doi:10.3760/cma.j.cn121090-20241125-00479
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。